Astoriom has appointed Will Edwards as its new CEO, as the company prepares for its next phase of international growth.
Edwards succeeds Lori A. Ball, who is stepping into a board role after leading the business through a period of expansion.
Headquartered in Rochdale, the business specialises in safeguarding high-value scientific research and consumer product samples, providing services spanning sample stability storage, biorepository solutions, validation services, storage design and disaster recovery.
It was founded over 30 years ago and operates environmentally controlled storage facilities across the UK, Ireland and the US.
Edwards brings more than two decades of international leadership experience across storage, logistics and technology.
Most recently, he served as CEO of Spectrum Storage Group, and has previously held roles at global organisations including Google and Bain & Co.
He also holds an MBA from INSEAD and an MS from Stanford University.
“Astoriom plays a critical role in protecting high-value scientific and product assets for customers operating in regulated environments,” said Mark Hammond, chairman at Astoriom.
“Will’s expertise scaling international companies in the storage sector and beyond is remarkable and will be instrumental in realizing the company’s full potential.
“His appointment reflects our confidence in his ability to lead the business through its next phase of growth, while maintaining the operational rigour, quality standards, and customer trust that define Astoriom’s proposition.
“We’d also like to thank outgoing CEO, Lori A. Ball for her dedicated leadership and look forward to continuing to work alongside her as she joins Astoriom’s board.”
Edwards added: “Astoriom has built a strong reputation as a global industry leader for quality, reliability, and technical excellence in a sector where trust and resilience are essential.
“The business has grown significantly in the last couple of years and is at an exciting stage of development.
“The team is committed to providing accessible stability storage and biorepository solutions to safeguard the integrity and viability of valuable sample assets; I look forward to working with them to continue to scale capabilities worldwide, while remaining firmly focused on compliance, operational excellence, and long-term customer partnerships.”